|
🐜
|
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma.
14 auth.
Yanhong Liu,
Hai-shi Zhang,
Keke Zhou,
Lina Chen,
Zhonghui Xu,
Yu Zhong,
Hongliang Liu,
Rui Li,
Y. Shugart,
Q. Wei,
...
Li Jin,
Feng-ping Huang,
D. Lu,
Liangfu Zhou
|
6 |
2007 |
6
🐜
|
|
🐜
|
Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
9 auth.
Lili Qian,
Jiajun Zheng,
Ke Wang,
Ying Tang,
Xiaofeng Zhang,
Hai-shi Zhang,
...
Feng-ping Huang,
Y. Pei,
Yanyan Jiang
|
6 |
2013 |
6
🐜
|
|
🐜
|
Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma
13 auth.
Yanhong Liu,
Keke Zhou,
Hai-shi Zhang,
Y. Shugart,
Lina Chen,
Zhonghui Xu,
Yu Zhong,
Hongliang Liu,
Li Jin,
Q. Wei,
...
Feng-ping Huang,
D. Lu,
Liangfu Zhou
|
6 |
2008 |
6
🐜
|
|
🐬
|
Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells
F. Ge,
Hai-shi Zhang,
D. Wang,
Linda Li,
P. Lin
|
5 |
2015 |
5
🐬
|
|
🐜
|
Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas
8 auth.
Fang Shen,
Yang Zhang,
Yu Yao,
W. Hua,
Hai-shi Zhang,
Jing-song Wu,
...
P. Zhong,
Liang‐fu Zhou
|
5 |
2014 |
5
🐜
|
|
🐜
|
XRCC3 haplotypes and risk of gliomas in a Chinese population: A hospital‐based case‐control study
12 auth.
Keke Zhou,
Yanhong Liu,
Hai-shi Zhang,
Hongliang Liu,
Wei-wei Fan,
Yu Zhong,
...
Zhonghui Xu,
Li Jin,
Q. Wei,
Feng-ping Huang,
D. Lu,
Liangfu Zhou
|
5 |
2009 |
5
🐜
|
|
🐜
|
Serum GFAP autoantibody as an ELISA-detectable glioma marker
8 auth.
P. Wei,
Wei Zhang,
Liu-song Yang,
Hai-shi Zhang,
Xiao-En Xu,
Yinghua Jiang,
...
Feng-ping Huang,
Qian Shi
|
5 |
2013 |
5
🐜
|
|
🐜
|
TMZ‐induced PrPc/par‐4 interaction promotes the survival of human glioma cells
8 auth.
Dongxiao Zhuang,
Yingchao Liu,
Y. Mao,
Liang Gao,
Hai-shi Zhang,
Shihai Luan,
...
Feng-ping Huang,
Qingquan Li
|
4 |
2012 |
4
🐜
|
